about
Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook.Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.Roseburia intestinalis inhibits interleukin‑17 excretion and promotes regulatory T cells differentiation in colitis.Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responsesRoseburia intestinalis-derived flagellin is a negative regulator of intestinal inflammationSystematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver DiseaseA new colitis therapy strategy via the target colonization of magnetic nanoparticle-internalized Roseburia intestinalisRoseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response
P50
Q39414517-685B1E1F-4EB2-4F8D-921A-230FBC6EC3D5Q49733575-23AFD015-F123-45DD-8590-423323714865Q55128199-569E7CE9-E866-4247-9DA0-B732DFB2BF7FQ88036114-2CE6BD70-5707-49C3-AF18-9798A2D91825Q88716823-1E699FAB-231A-4D35-9B36-8FD200D7001EQ92307491-CCCFB2AD-9684-404F-87DC-FE21E2E2783BQ92413062-86EB6BE4-2CE4-41C9-9266-A10EE1285107Q92582080-98B1C201-B0D4-41C8-ACA5-17931F2D7209
P50
description
researcher (ORCID 0000-0002-0000-420X)
@en
wetenschapper
@nl
name
Weiwei Luo
@en
Weiwei Luo
@nl
type
label
Weiwei Luo
@en
Weiwei Luo
@nl
prefLabel
Weiwei Luo
@en
Weiwei Luo
@nl
P31
P496
0000-0002-0000-420X